WhaleQuant.io
Gilead Sciences, Inc. (GILD) Corporate Logo

Gilead Sciences, Inc. (GILD) Stock Price & Analysis

Market: NASDAQ • Sector: Healthcare • Industry: Drug Manufacturers - General

Gilead Sciences, Inc. (GILD) Profile & Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Key Information

Ticker GILD
Exchange NASDAQ
Official Site https://www.gilead.com
CIK Number 0000882095
View SEC Filings

Market Trend Overview for GILD

One model, two time views: what the market looks like right now, and where the larger trend is heading over time.

Longer-Term Market Trend (Mid to Long Term)

Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-11-17 (ET)

As of 2026-11-17, GILD is moving sideways without a clear direction. Over the longer term, the trend remains bullish.

GILD last closed at 170.26. The price is about 1.2 ATR above its recent average price (165.30), and the market is currently in a sideways market without a clear direction. Price at 170.26 is moving between minor support near 164.00 and minor resistance near 175.65. Direction remains unclear. View Support & Resistance from Options

The market is moving sideways, with no clear direction. Both upside and downside risks remain in play.

Trend Alignment Summary

Trend score: 35 out of 100. Overall alignment is unclear. The market is currently in a sideways market without a clear direction. The longer-term trend is still positive, but short-term signals are not yet confirming it.

Key Risk Level

A key downside risk boundary is near 149.62. If price falls below this area, the current structure would likely weaken further.

Recent Trend Signal

A systematic trend-activation signal was most recently triggered on 2026-10-15, reflecting a technical shift toward positive directional alignment.

Unusual Price Movement

[2026-11-17] Moderate participation supported a steady price advance.

Recent Price Behavior

Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.

Overnight Positioning

There was no clear sign of meaningful positions being carried into the overnight session.

Next-day directional probability forecast Last updated: 2026-11-17 (ET)
Next-session outlook for 2026-11-18 (ET)
Mild bullish lean, but not actionable

What the model sees

The model still sees a directional lean, but the edge is not thick enough after adjusting for reward/risk.


Why the model says this

The model does not deploy this setup because the directional lean exists, but the edge is still not thick enough after risk adjustment and reward/risk remains too thin at 0.12 after adjustment. Predictability is 46%, agreement is 93%, and reversal risk is 16%.

NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history

Recent Cost Distribution Last updated: 2026-11-17 (ET)

This estimate uses 1-minute price, volume, and VWAP data from the last 55 trading days, with turnover-based decay. The sample period is 2026-09-01 to 2026-11-17. The current price is 170.26, 8.16% above the estimated average cost of 157.42. An estimated 86.5% of recent positioning is below the current price, while 12.7% is above it. The peak-density price is 150.90. The largest concentrated cost region is 148.85 to 151.55 and contains 20.4% of the estimated distribution. The current price is within the 169.05 to 171.35 cost region. The nearest region below the current price is 167.35 to 168.35. The nearest region above the current price is 174.45 to 174.75.

Short Interest & Covering Risk for GILD

This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.

Squeeze Score 0.70

Shows how likely a short squeeze may be under current market conditions.

Key Market Risk Indicators
Short Crowding (Short Interest / Float) 1.72%
Short Positions Trend Increasing
Liquidity Trend (Average Daily Volume) 22.79%
20-Day Return 8.79%
Price vs 20-Day High Below Recent Highs

Short Exposure Percentile

Short interest is well above normal levels, increasing the risk of forced covering and sudden price moves. (Historical percentile: 82%)

Structure Analysis

GILD Short positioning looks normal. Current days to cover is 3.2 trading days, meaning short positions could unwind at a normal pace. Short covering is likely to have a normal impact on price moves. No meaningful structural fragility is currently detected (Fragility Score 19/100, DTC percentile 67%) while price maintains a mild upward bias (20D return 8.8%) with short positioning continuing to expand.

Risk Summary

No clear bull trap characteristics detected. Recent price behavior remains broadly consistent with current positioning.This reading helps confirm that current price action remains structurally healthy and does not indicate elevated trap risk.

Why Price Reactions May Be Stronger?

In the latest reporting period, short interest continues to increase. Price action is compressing (range is tightening), which can make breaks more sensitive. Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. As a result, similar news or market events could lead to price moves about 1× larger than usual.


Note: Short interest data is reported every two weeks by FINRA. The most recent snapshot is 2026-10-30 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.

Analytical Modules